Home Berkeley Law Library -- Reference & Research Services Ars Technica » Scientific Method Ambry hits back at Myriad’s “bad faith enforcement” of breast cancer gene patents

Ambry hits back at Myriad’s “bad faith enforcement” of breast cancer gene patents

Ars Technica » Scientific Method 2013-08-07

Summary:

Patents were knocked out by Supreme Court—but Myriad is still suing competitors.
    

Link:

http://feeds.arstechnica.com/~r/arstechnica/science/~3/72iYHIslZbE/story01.htm

From feeds:

Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method

Tags:

scientific method gene patents myriad genetics brca ambry genetics

Authors:

Joe Mullin

Date tagged:

08/07/2013, 14:30

Date published:

08/07/2013, 09:23